Dactylitis was numerically, but not statistically, improved with golimumab relative to placebo
Additional Breakthrough T1D-funded research on GLP-1 and SGLT therapies is investigating the benefits of these drugs for people with T1D, including reducing the risk of common complications of type 1 diabetes like cardiovascular disease and kidney disease
This suggests that epitalon may help healthy cells age more effectively, while having a different effect on cancer cells (2)
Its efficiency on peptide-bound CML improved more than tenfold compared with the starting enzyme
According to Lilly, Plaintiffs have already sought discovery concerning conditions such as malnutrition, dehydration, pulmonary aspiration, Wernickes encephalopathy, pancreatitis, and acute kidney injury
Damianaki A, Vagiakis E, Sigala I, et al